Skip to Main Content

Paper Details

Antimicrobial Drug Development Efficiency and Surrogate Markers of Clinical Benefit.
JAMA Intern Med
1
2020
Author NameAffiliation
Paul VolberdingUniversity of California San Francisco, AIDS Research Institute, University of California San Francisco.
  • 1 - 1

Datasets

Release 1.2